Cargando…
A Nitric Oxide-Releasing Heparin Conjugate for Delivery of a Combined Antiplatelet/Anticoagulant Agent
[Image: see text] Heparin is a widely used anticoagulant due to its ability to inhibit key components in the coagulation cascade such as Factor Xa and thrombin (Factor IIa). Its potential to preferentially bind to antithrombin (ATIII) results in a conformational change and activation that leads to t...
Autores principales: | Suchyta, Dakota J., Handa, Hitesh, Meyerhoff, Mark E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3993940/ https://www.ncbi.nlm.nih.gov/pubmed/24423090 http://dx.doi.org/10.1021/mp400501c |
Ejemplares similares
-
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
por: Winzely, Maximilian, et al.
Publicado: (2021) -
Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices
por: Goudie, Marcus J., et al.
Publicado: (2017) -
Statement on Antiplatelet Agents and Anticoagulants in Cardiology -
2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019) -
Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016) -
Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)